ANG Lifesciences India Limited

About

ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, and lotions. ANG Lifesciences India Limited was incorporated in 2006 and is based in Amritsar, India.

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	13.96	22.80	18.30	25.97	24.53	17.67	23.91	32.16	16.18	34.08	17.10	29.58	50.61
Expenses	15.42	18.18	20.37	23.75	22.67	18.03	25.89	29.70	18.11	30.23	18.82	28.26	44.94
Operating Profit	-1.46	4.62	-2.07	2.22	1.86	-0.36	-1.98	2.46	-1.93	3.85	-1.72	1.32	5.67
OPM %	-10.46	20.26	-11.31	8.55	7.58	-2.04	-8.28	7.65	-11.93	11.30	-10.06	4.46	11.20
Other Income	0.19	0.19	0.16	0.21	0.17	0.75	-0.03	0.36	1.36	-1.49	-0.09	0.33	0.34
Depreciation	1.47	1.73	1.45	1.45	1.45	1.30	1.84	1.62	1.51	1.83	2.02	1.97	1.94
Interest	1.77	1.65	1.61	1.59	1.61	2.05	1.71	1.87	1.67	3.44	1.99	1.96	1.94
Profit before tax	-4.51	1.43	-4.97	-0.61	-1.03	-2.96	-5.56	-0.67	-3.75	-2.91	-5.82	-2.28	2.13
Tax %	-24.17	23.08	-14.89	29.51	-23.30	-34.46	-17.99	61.19	-26.13	23.71	-20.96	-10.09	25.35
Net Profit	-3.42	1.10	-4.24	-0.80	-0.79	-1.94	-4.57	-1.07	-2.77	-3.60	-4.59	-2.05	1.60
EPS in Rs	-2.62	0.84	-3.25	-0.61	-0.60	-1.49	-3.50	-0.82	-2.12	-2.76	-3.52	-1.57	1.23

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	91.60	89.73	131.30	206.82	348.52	154.24	126.08	121.27	75.13	66.93	54.92	36.84
Expenses	84.99	90.75	121.75	195.15	282.98	138.91	113.65	109.63	67.83	60.43	50.19	33.72
Operating Profit	6.61	-1.02	9.55	11.67	65.54	15.33	12.43	11.64	7.30	6.50	4.73	3.12
OPM %	7.22	-1.14	7.27	5.64	18.81	9.94	9.86	9.60	9.72	9.71	8.61	8.47
Other Income	0.73	1.99	-0.89	9.84	0.95	0.75	0.42	0.23	0.69	0.25	0.21	0.09
Interest	6.45	7.64	9.77	10.92	8.31	3.98	3.22	2.64	1.85	1.77	1.66	1.66
Depreciation	6.08	6.27	7.75	8.52	5.12	2.24	1.23	1.12	1.19	1.17	1.06	0.95
Profit before tax	-5.19	-12.94	-8.86	2.07	53.06	9.86	8.40	8.11	4.95	3.81	2.22	0.60
Tax %	-8.86	-20.02	-2.48	131.88	25.18	26.47	27.50	30.33	24.65	25.98	25.23	31.67
Net Profit	-4.73	-10.34	-8.65	-0.66	39.71	7.25	6.10	5.65	3.72	2.82	1.65	0.40
EPS in Rs	-3.62	-7.92	-6.62	-0.51	30.55	5.58	4.69	4.35	2.86	3.07	1.79	0.43
Dividend Payout %	0.00	0.00	0.00	0.00	2.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	13.06	13.06	13.06	13.06	10.37	5.18	5.18	5.18	5.18	3.68	3.68	3.68
Reserves	49.16	53.75	64.01	72.48	73.11	36.17	29.37	23.58	17.99	3.81	1.09	-0.57
Borrowings	66.84	70.58	59.36	55.56	60.99	42.40	20.83	21.90	17.42	14.01	11.77	10.15
Other Liabilities	60.85	71.28	81.00	111.40	124.21	58.49	38.69	30.24	27.57	25.34	18.95	12.59
Total Liabilities	189.91	208.67	217.43	252.50	268.68	142.24	94.07	80.90	68.16	46.84	35.49	25.85
Fixed Assets	47.05	52.63	53.35	78.68	82.32	21.89	20.94	20.60	9.47	8.90	9.02	8.78
CWIP	0.00	0.00	0.00	0.00	0.00	0.40	0.23	0.16	11.57	0.07	0.00	0.00
Investments	3.52	3.52	3.52	3.52	3.52	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Other Assets	139.34	152.52	160.56	170.30	182.84	119.93	72.88	60.12	47.10	37.85	26.45	17.05
Total Assets	189.91	208.67	217.43	252.50	268.68	142.24	94.07	80.90	68.16	46.84	35.49	25.85

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash from Operating Activity	13.72	-2.29	-13.13	26.01	27.39	-11.18	4.83	7.46	0.88	2.73	1.86	3.13
Cash from Investing Activity	-3.33	-1.63	20.02	-9.35	-42.50	-7.79	-1.66	-0.77	-13.40	-2.56	-2.92	-2.32
Cash from Financing Activity	-10.19	3.92	-7.00	-16.75	15.29	18.81	-3.95	-3.80	13.10	-0.29	1.63	-0.89
Net Cash Flow	0.20	-0.01	-0.12	-0.08	0.17	-0.16	-0.77	2.89	0.57	-0.12	0.56	-0.08
Free Cash Flow	9.63	-6.41	5.93	15.58	-11.96	-15.25	3.19	6.62	-12.38	1.61	0.55	2.43
CFO/OP %	208.00	-186.00	3.00	252.00	43.00	-69.00	60.00	84.00	26.00	54.00	48.00	103.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Debtor Days	260.40	264.24	192.56	137.85	103.67	139.10	133.34	125.66	156.19	139.39	108.86	62.22
Inventory Days	206.64	227.95	143.34	92.90	46.29	67.62	41.03	27.18	53.41	44.62	46.81	84.14
Days Payable	250.41	333.86	243.56	153.93	105.16	158.84	105.80	90.63	153.96	163.44	133.28	129.88
Cash Conversion Cycle	216.63	158.34	92.34	76.83	44.80	47.88	68.56	62.21	55.64	20.58	22.39	16.48
Working Capital Days	19.17	71.80	74.97	27.88	22.05	47.14	52.60	39.70	48.29	14.40	10.23	18.73
ROCE %	0.95	-3.54	1.78	8.51	53.78	19.90	21.92	23.56	21.90	29.34	26.04	16.74

Shareholding Pattern

% holding — latest first

Holder	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Promoters	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60
Public	29.40	29.41	29.40	29.40	29.39	29.39	29.39	29.39	29.39	29.39	29.41	29.38
No. of Shareholders	5,952	6,084	6,273	6,400	6,508	6,517	6,468	6,631	6,868	6,918	7,055	7,305